Author(s): Galvn CA, Elbarcha OC, Fernndez EJ, Beltramo DM, Soria NW
Abstract Share this page
Abstract BACKGROUND: The most important factor limiting the success of an antiretroviral therapy is toxicity. The HLA-B*5701 allele is predictive of hypersensitivity reaction to Abacavir, and this gene is in a perfect linkage disequilibrium with the rs2395029 SNP present in the HCP5 gene. METHODS: Genomic DNA was extracted from blood obtained from 201 unrelated healthy Argentinean volunteers. The DNA was subjected to an allele-specific PCR method. Sequencing was performed to validate the test results. RESULTS: We were successful to amplify specific fragment of interest from the DNA samples. The method is easy, specific and reproducible. CONCLUSIONS: The application of this methodology is a rapid and simple method to detect the HCP5 polymorphism (rs2395029) previous to administration of Abacavir in patients with HIV infection. Copyright © 2011 Elsevier B.V. All rights reserved.
This article was published in Clin Chim Acta
and referenced in Journal of Pharmacogenomics & Pharmacoproteomics